Oftalmol Zh.2009;3:74-80.

http://doi.org/10.31288/oftalmolzh200937480

THE CLINICAL-MORPHOLOGYCAL FACTORS OF THE RISK OF DEATH OF PATIENTS WITH EPITHELIAL TUMORS OF THE LACRIMAL GLAND

S. I. Polyakova

Odessa, Ukraine

The factors which influence the survival rate of patients with epithelial tumors of the lacrimal gland (ETLG) was investigated in 219 patients who were treated in the Filatov Institute. The following up period was from 1 month to 435 months.

In the terms of investigation 134 patients (61,2%) survived, 85 (38,8%) died. 79 from the 85 dead patients had metastatic disease or intracranial growth of the tumors; 6 patients died from another causes and they were excluded from analyses.

It was established that the survival rate of patients with ETLG depends on such factors as sex, age, size of tumor, the presence of capsula, destruction of orbital bones, tumor recurrence.

The cox-regressive model was development, on which basis 6 groups of hazard for survival rate of patients with ETLY were categorized. The worst factors for poor outcome of the lacrimal gland tumor were diameter more than 54 mm and the histological type of tumor — adenocarcinoma.

 

References

1.Бровкина А. Ф. Болезни орбиты: руководство для врачей. — 2-е изд. — М.: ООО «Медицинское информа-ционное агентство», 2008. — 256 с.

2.Офтальмоонкология: Руководство для врачей / А. Ф. Бровкина, В. В. Вальский, Г. А. Гусев и др.; Под ред. А. Ф. Бровкиной. — М.: Медицина, 2002. — 242 с.

3.Полякова С. И. // Автореф. канд. ... дис. «Дифференциальная диагностика и эффективность лечения новообразований слезной железы различного гистогенеза». — Одесса, 1988. — 17 с.

4.Флетчер Р., Флетчер С., Вагнер Э. Клиническая эпидемиология. Основы доказательной медицины. — М.: Медиа Сфера, 1998. — 352 с.

5.Auran J. Jakobiec F. F., Krebs W. Benign mixed tumor of the palpebral lobe of the lacrimal gland. Clinical diagnosis and appropriate surgical management // Ophthalmology. — 1988. — Vol. 95, № 1. — P. 90-99.

CrossRef  

6.Bellman B., Gregory N., Silvers D., Fountain K. Sweat gland carcinoma with metastases to the skin // Cutis. — 1995. — Vol. 55, № 4. — P. 221-224.

7.Berkson J., Gage R. R. The calculation of survival rates for cancer. Proceedings of Staff Meetings, Mayo Clini. — 1950. — № 25. — P. 250.

8.Chuo Ni, Shu Chu Cheg, Druja T., Tao Yu Cheng. Lacrimal gland tumours: A clinico-pathological analysis of 160 cases // Ophthalm. Clin. — 1982. — Vol. 22, № 1. — P. 99-120.

CrossRef  PubMed

9.Hald A. Maximum likelihood estimation of the parameters of a normal distribution which is truncated at a known point // Skandinavisk Aktuarietidskrift, 1949. — P. 119134.

CrossRef  

10.Hartwick R. W., Shaw P. A., Srigley J. R., Hurwitz J. J. In situ adenocarcinoma ex pleomorphic adenoma of the lacrimal gland // Canad. J. Ophthalmol. — 1990. — Vol. 25, № 4. — P. 213-217.

11.Henderson J. W. Orbital tumors. — Raven Press, New Your, 1994. — 448 p.

12.Jordan D. R., Addison D. J., Watson A. G., McLeish W. A. Adenocarcinoma of the lacrimal gland with metastasis to the preauricular lymph nodes and parotid gland // Ca-nad. J. Ophthalmol. — 1988. — Vol. 23, № 3. — P. 136140.

13.Kaplan E. L., Meier P. Nonparametric estimation from in-complete observations // Journal of the American Statistical Association. — 1958. — № 53. — P. 457-481.

CrossRef 

14.Rose Geoffrey E., Wright John E. Pleomorphic adenoma of ht lacrimal gland // Brit. J. Ophthalmol. — 1992. — Vol. 76, № 7. — P. 398-401.

CrossRef  PubMed 

15.Rosenbaum P., Mahadevia P., Goodman L. Acinic Cell Carcinoma of the Lacrimal Glands // Arch. Ophthal. — 1995. — Vol. 113, № 6. — P. 781-785.

CrossRef  PubMed 

16.Shields C. L., Shields J. A., Eagle R. C., Rathmell J. P. Clinicopathologic review of cases of lacrimal gland lesions // Ophthalmology. — 1989. — Vol. 96, № 4. — P. 431435.

CrossRef  

17.Wright John E., Rose Geoffrey E., Garner Abc. Primary malignant neoplasms of the lacrimal gland // Brit. J. Oph-thalmol. — 1992. — Vol. 76, № 7. — P. 401-407.

CrossRef  PubMed